Current Portion Of Long Term Debt - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Current Portion of Long-Term Debt Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Current Portion of Long-Term Debt
zł327k
CAGR 3-Years
-52%
CAGR 5-Years
-47%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medicofarma Biotech SA
WSE:MDB
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Current Portion of Long-Term Debt
zł47.9m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
327k PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Current Portion of Long-Term Debt amounts to 327k PLN.

What is Ryvu Therapeutics SA's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-47%

Over the last year, the Current Portion of Long-Term Debt growth was -80%. The average annual Current Portion of Long-Term Debt growth rates for Ryvu Therapeutics SA have been -52% over the past three years , -47% over the past five years .

Back to Top